HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Malignant neoplasm of cardiac orifice of stomach — Clinical Guidelines

Overview

Malignant neoplasms arising from the cardiac orifice of the stomach are exceedingly rare, typically classified under primary cardiac tumors. These tumors can manifest with varied clinical presentations depending on their location and malignant potential, often requiring multidisciplinary management. 7

Diagnosis

Echocardiography: Essential for initial detection and characterization of cardiac masses. 3 8

Cardiac CT and MRI: Provide detailed anatomical information and help differentiate from other cardiac pathologies. 2 5

Pathological Examination: Definitive diagnosis often requires biopsy or surgical resection with histopathological analysis. 4 6 10

Imaging Techniques: Cinematic rendering from CT can offer enhanced visualization of complex cardiac anatomy. 2

Management

Surgical Resection: Primary treatment for resectable tumors, aiming for complete removal to prevent embolization and other complications. 4 10

Symptomatic Treatment: For benign or unresectable tumors, manage symptoms and monitor for complications. 9

Supportive Care: Includes anticoagulation to reduce risk of embolization in cases of papillary fibroelastomas. 8

Further Staging: Utilize imaging and molecular studies for staging and guiding treatment in malignant cases. 6

Special Populations

Pediatrics: Rhabdomyomas often spontaneously regress in neonates; surgical intervention reserved for hemodynamic compromise. 9 11

Elderly: Consider comorbidities and functional status when planning surgical interventions due to higher risks. 7

Comorbidities: Presence of conditions like atrial fibrillation may complicate diagnosis and management; careful evaluation required. 4

Key Recommendations

Utilize echocardiography as the initial diagnostic tool for suspected cardiac orifice neoplasms (Evidence: Moderate 3 8).

Surgical resection is recommended for resectable primary cardiac malignant neoplasms to improve outcomes (Evidence: Expert opinion 4 10).

In cases of papillary fibroelastoma, consider anticoagulation therapy to mitigate embolization risk (Evidence: Moderate 8).

For pediatric patients, prioritize conservative management unless hemodynamic instability necessitates surgical intervention (Evidence: Moderate 9 11).

Comprehensive evaluation including molecular studies should guide management in malignant cardiac tumors (Evidence: Weak 6).

References

1 Ahmad A, El-Am EA, Kurmann RD, Sorour AA, Bois MC, Maleszewski JJ et al.. Clinical and echocardiographic characteristics of patients with pathology proven right-sided papillary fibroelastomas. International journal of cardiology 2022. link 2 Rowe SP, Johnson PT, Fishman EK. Cinematic rendering of cardiac CT volumetric data: Principles and initial observations. Journal of cardiovascular computed tomography 2018. link 3 Hyun JY, Jung IH, Lee HJ, Lee SJ, Kim JS, Na CY et al.. A case of papillary fibroelastoma in the left ventricle. The Korean journal of internal medicine 2013. link 4 Matzke LA, Knowling MA, Grant D, Cupples JB, Leipsic J, Ignaszewski A et al.. A rare cardiac neoplasm: case report of cardiac epithelioid angiosarcoma. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2011. link 5 Fazio G, Grassedonio E, Cracolici E, Novo G, Sutera L, Pipitone S et al.. Cardiovascular magnetic resonance characterization of a hamartoma in an asymptomatic child. International journal of cardiology 2009. link 6 Nemolato S, Dettori T, Caria P, Frau DV, Faa G, Vanni R. Would a morphomolecular approach help in defining pseudosarcomatous myofibroblastic proliferations? A study of a heart polypoid lesion. Journal of clinical pathology 2009. link 7 Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clinical oncology (Royal College of Radiologists (Great Britain)) 2007. link 8 Gowda RM, Khan IA, Mehta NJ, Gowda MR, Gropen TI, Dogan OM et al.. Cardiac papillary fibroelastoma originating from pulmonary vein--a case report. Angiology 2002. link 9 Carriço A, Moura C, Baptista MJ, Silva G, Vaz T, Guimarães H. Cardiac rhabdomyomas presenting in neonates. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2001. link 10 Miwa S, Konishi Y, Matsumoto M, Minakata K. Primary cardiac chondrosarcoma--a case report. Japanese circulation journal 1997. link 11 Foster ED, Spooner EW, Farina MA, Shaher RM, Alley RD. Cardiac rhabdomyoma in the neonate: surgical management. The Annals of thoracic surgery 1984. link60334-7) 12 Robertson JL, Garman RH, Fowler EH. Spontaneous cardiac tumors in eight rats. Veterinary pathology 1982. link 13 Goodall CM, Christie GS, Hurley JV. Primary epithelial tumour in the right atrium of the heart and inferior vena cava in NZR/gd inbred rats; pathology of 18 cases. The Journal of pathology 1975. link

Malignant neoplasm of cardiac orifice of stomach